UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 38

Sortiert nach

Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response

Hepatology international, 2023-08, Vol.17 (4), p.1045-1056

2023

Link zum Volltext

Verfügbarkeit prüfen

The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model

Biomedicines, 2021-01, Vol.9 (1), p.60

2021

Link zum Volltext

Verfügbarkeit prüfen

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview

International journal of molecular sciences, 2020-03, Vol.21 (6), p.2027

2020

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension

iScience, 2024-03, Vol.27 (3), p.109301-109301, Article 109301

2024

Link zum Volltext

Verfügbarkeit prüfen

Vascular Targets for the Treatment of Portal Hypertension

Seminars in liver disease, 2019-11, Vol.39 (4), p.483

2019

Link zum Volltext

Verfügbarkeit prüfen

Nuclear receptors in liver fibrosis

Biochimica et biophysica acta. Molecular basis of disease, 2021-12, Vol.1867 (12), p.166235-166235, Article 166235

2021

Link zum Volltext

Verfügbarkeit prüfen

In silico characterization of the interactome of hepatic nonparenchymal cells reveals promising targets for antifibrotic therapy

Journal of hepatology, 2022-07, Vol.77, p.S360

2022

Link zum Volltext

Verfügbarkeit prüfen

SAT-345 - Bacterial translocation has an early onset in cirrhosis and induces a selective inflammatory response

Journal of hepatology, 2023-06, Vol.78, p.S294-S294

2023

Link zum Volltext

Verfügbarkeit prüfen

Collagen-proportionate area determined by semiautomated histomorphometry correlates with HVPG across different liver disease etiologies

Journal of hepatology, 2023-06, Vol.78, p.S316-S317

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT-553 - Collagen-proportionate area determined by semiautomated histomorphometry correlates with HVPG across different liver disease etiologies

Journal of hepatology, 2023-06, Vol.78, p.S316-S317

2023

Link zum Volltext

Verfügbarkeit prüfen

Systemic inflammation remains a critical determinant of the dynamic component of portal hypertension in abstinent patients with alcohol-related cirrhosis

Journal of hepatology, 2023-06, Vol.78, p.S289

2023

Link zum Volltext

Verfügbarkeit prüfen

SAT-336 - Systemic inflammation remains a critical determinant of the dynamic component of portal hypertension in abstinent patients with alcohol-related cirrhosis

Journal of hepatology, 2023-06, Vol.78, p.S289-S289

2023

Link zum Volltext

Verfügbarkeit prüfen

THU-357 - Distinct patterns of hepatic and systemic inflammation in different types/aetiologies of liver disease

Journal of hepatology, 2023-06, Vol.78, p.S222-S224

2023

Link zum Volltext

Verfügbarkeit prüfen

Bacterial translocation has an early onset in cirrhosis and induces a selective inflammatory response

Journal of hepatology, 2023-06, Vol.78, p.S294

2023

Link zum Volltext

Verfügbarkeit prüfen

Distinct patterns of hepatic and systemic inflammation in different types/aetiologies of liver disease

Journal of hepatology, 2023-06, Vol.78, p.S222-S224

2023

Link zum Volltext

Verfügbarkeit prüfen

Loss of bile salt export pump (BSEP/ABCB11) protects mice from development of carbon tetrachloride (CCl4) induced hepatic fibrosis

Journal of hepatology, 2022-07, Vol.77, p.S469

2022

Link zum Volltext

Verfügbarkeit prüfen

Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension

Advances in medical sciences, 2022-03, Vol.67 (1), p.154-162

2022

Link zum Volltext

Verfügbarkeit prüfen

Extracellular vesicles carrying oxidation-specific epitopes as effectors in acute hepatic decompensation and acute-on-chronic liver failure-a pilot study

Journal of hepatology, 2023-06, Vol.78, p.S224

2023

Link zum Volltext

Verfügbarkeit prüfen

THU-358 - Extracellular vesicles carrying oxidation-specific epitopes as effectors in acute hepatic decompensation and acute-on-chronic liver failure-a pilot study

Journal of hepatology, 2023-06, Vol.78, p.S224-S224

2023

Link zum Volltext

Verfügbarkeit prüfen

Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies

Hepatology (Baltimore, Md.), 2022-03, Vol.75 (3), p.610-622

2022

Link zum Volltext

Verfügbarkeit prüfen

Hemodynamic, molecular, and histological characterization of a toxic liver fibrosis regression model

Journal of hepatology, 2022-07, Vol.77, p.S472-S473

2022

Link zum Volltext

Verfügbarkeit prüfen

Dual inhibition of integrins alpha-v/beta-6 and alpha-v/beta-1 decreases portal pressure and liver fibrosis in rats with biliary cirrhosis

Journal of hepatology, 2022-07, Vol.77, p.S468-S469

2022

Link zum Volltext

Verfügbarkeit prüfen

Soluble guanylyl cyclase expression and signaling in different types of liver fibrosis

Journal of hepatology, 2022-07, Vol.77, p.S753-S754

2022

Link zum Volltext

Verfügbarkeit prüfen

FRI-127-Measuring dynamics of portal pressure and vital parameters in conscious rats using real-time telemetry

Journal of hepatology, 2019-04, Vol.70 (1), p.e443-e443

2019

Link zum Volltext

Verfügbarkeit prüfen

Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease

Liver international, 2022-11, Vol.42 (11), p.2501-2512

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 38

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Bacterial translocation occurs early in cirrhosis and triggers a selective inflammatory response

The Non-Steroidal FXR Agonist Cilofexor Improves Portal Hypertension and Reduces Hepatic Fibrosis in a Rat NASH Model

Recent Advances in Practical Methods for Liver Cell Biology: A Short Overview

Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension

Vascular Targets for the Treatment of Portal Hypertension

Nuclear receptors in liver fibrosis

In silico characterization of the interactome of hepatic nonparenchymal cells reveals promising targets for antifibrotic therapy

SAT-345 - Bacterial translocation has an early onset in cirrhosis and induces a selective inflammatory response

Collagen-proportionate area determined by semiautomated histomorphometry correlates with HVPG across different liver disease etiologies

SAT-553 - Collagen-proportionate area determined by semiautomated histomorphometry correlates with HVPG across different liver disease etiologies

Systemic inflammation remains a critical determinant of the dynamic component of portal hypertension in abstinent patients with alcohol-related cirrhosis

SAT-336 - Systemic inflammation remains a critical determinant of the dynamic component of portal hypertension in abstinent patients with alcohol-related cirrhosis

THU-357 - Distinct patterns of hepatic and systemic inflammation in different types/aetiologies of liver disease

Bacterial translocation has an early onset in cirrhosis and induces a selective inflammatory response

Distinct patterns of hepatic and systemic inflammation in different types/aetiologies of liver disease

Loss of bile salt export pump (BSEP/ABCB11) protects mice from development of carbon tetrachloride (CCl4) induced hepatic fibrosis

Splenectomy ameliorates portal pressure and anemia in animal models of cirrhotic and non-cirrhotic portal hypertension

Extracellular vesicles carrying oxidation-specific epitopes as effectors in acute hepatic decompensation and acute-on-chronic liver failure-a pilot study

THU-358 - Extracellular vesicles carrying oxidation-specific epitopes as effectors in acute hepatic decompensation and acute-on-chronic liver failure-a pilot study

Distinct structural and dynamic components of portal hypertension in different animal models and human liver disease etiologies

Hemodynamic, molecular, and histological characterization of a toxic liver fibrosis regression model

Dual inhibition of integrins alpha-v/beta-6 and alpha-v/beta-1 decreases portal pressure and liver fibrosis in rats with biliary cirrhosis

Soluble guanylyl cyclase expression and signaling in different types of liver fibrosis

FRI-127-Measuring dynamics of portal pressure and vital parameters in conscious rats using real-time telemetry

Systemic inflammation is linked to liver fibrogenesis in patients with advanced chronic liver disease

Suchergebnisse filtern